WEDNESDAY, June 19, 2019 -- Sudden unexpected death in epilepsy is rare and thought to mainly affect people with hard-to-treat seizures, but a new study suggests that even people with well-controlled epilepsy may be at risk.
That was especially true if someone had missed their last dose of medication or was sleep-deprived, the researchers found. Drinking too much alcohol was also implicated in some of the sudden unexpected death in epilepsy (SUDEP) cases they studied.
WEDNESDAY, June 5, 2019 -- The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that's the first to cut the frequency of cluster headaches.
Episodic cluster headaches are "an extremely painful and often debilitating condition," the FDA's Dr. Eric Bastings noted in an agency news release. He's deputy director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research.
TUESDAY, April 30, 2019 -- There's new data supporting the use of Epidiolex -- the first cannabidiol (CBD) medicine approved by the U.S. Food and Drug Administration -- to help curb a form of epilepsy.
The research found that the drug reduced seizures by nearly half in children with Dravet syndrome, a rare and severe form of the neurological disorder.